CATrends: Tequilas Marketed as 100% Agave
Ingredient claims come into the limelight.
Camarena et al. v. CBR Systems, Inc.
24-cv-21159, S.D. Fla.
(March 2024)
CBR’s umbilical cord blood banking program
Deceptively representing that stored umbilical cord blood and tissue may be used to treat at least 80 serious medical conditions and may be approved to treat additional medical conditions and injuries in the future when the FDA has approved cord blood to treat only seven medical conditions and has not approved cord tissue to treat any medical condition
Failing to disclose that the odds of being able to use the child’s own cord blood or tissue as a treatment is “virtually zero” because the child’s cord blood often contains the defects that caused the medical condition
Pending
Ingredient claims come into the limelight.
Beware of food images wrapped in deception.
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.